NewEdge Advisors’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$286K Buy
11,632
+1,739
+18% +$40.2K ﹤0.01% 2529
2026
Q1
$237K Buy
9,893
+8,797
+803% +$215K ﹤0.01% 2510
2025
Q4
$24.8K Buy
1,096
+627
+134% +$13.6K ﹤0.01% 3185
2025
Q3
$9.45K Buy
469
+109
+30% +$1.83K ﹤0.01% 3341
2025
Q2
$5.14K Sell
360
-251
-41% -$2.93K ﹤0.01% 3403
2025
Q1
$6.42K Hold
611
﹤0.01% 3229
2024
Q4
$7.4K Hold
611
﹤0.01% 3119
2024
Q3
$8.97K Hold
611
﹤0.01% 2978
2024
Q2
$8.82K Sell
611
-121
-17% -$1.93K ﹤0.01% 2900
2024
Q1
$11.9K Sell
732
-165
-18% -$2.58K ﹤0.01% 2814
2023
Q4
$13.4K Buy
897
+597
+199% +$6.76K ﹤0.01% 2736
2023
Q3
$3.37K Buy
+300
New +$3.48K ﹤0.01% 2919
2023
Q1
Sell
-1,288
Closed -$14.1K 3620
2022
Q4
$14.1K Buy
+1,288
New +$16.1K ﹤0.01% 2251

Other funds holding ELAN

NewEdge Advisors's ELAN Position: Q2 2026 in Review

NewEdge Advisors increased its Elanco Animal Health (ELAN) stake by 18% in Q2 2026, buying an estimated $40.2K and bringing the position to 11,632 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #2529.

NewEdge Advisors first reported a position in ELAN in Q4 2022 and has held it in 13 quarters since. 521 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • NewEdge Advisors held 11,632 shares of Elanco Animal Health worth $286K as of Q2 2026.
  • NewEdge Advisors bought 1,739 Elanco Animal Health shares in Q2 2026, an estimated $40.2K.
  • Elanco Animal Health made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2529 holding.
  • NewEdge Advisors first reported a position in Elanco Animal Health in Q4 2022 and has held it in 13 quarters since.
  • 521 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.